Tsuruhei Sukegawa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In Japan, multiple antipsychotic drugs are administered at a high dose to schizophrenia patients. Many patients suffer from side effects, among which extrapyramidal and autonomic side effects frequently occur. We suggest a method in which antipsychotic drugs are slowly reduced as follows: for low potency drugs, the dose is decreased with 25 mg or lower of a(More)
BACKGROUND In Japan, combination therapy with high doses of antipsychotic drugs is common, but as a consequence, many patients with schizophrenia report extrapyramidal and autonomic nervous system side effects. To resolve this, we proposed a method of safety correction of high dose antipsychotic polypharmacy (the SCAP method), in which the initial total(More)
Department of Mental Health Policy and Evaluation, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan (Dr Yamanouchi); National Hospital Organization, Tottori Medical Center, Tottori, Japan (Dr Sukegawa); School of International Politics, Economics and Communication, Aoyama Gakuin University, Tokyo, Japan (Dr(More)
Compared with other countries, Japan exhibits prominent levels of antipsychotic polypharmacy and high-dose regimens. In view of these circumstances, the Safe Correction of Antipsychotic Polypharmacy and high-dose regimens (SCAP) method was developed based on previous findings as a realistic way to reduce medication consumption in patients already(More)
In Japan, multiple antipsychotic drugs are administered at a high dose to schizophrenia patients, which is rare in other countries. Many of such patients suffer from side effects, among which extrapyramidal and autonomic side effects frequently occur. Many anticholinergic agents and cathartics are concomitantly used for schizophrenia patients, and their(More)
BACKGROUND Polypharmacy for schizophrenia treatment is not justified by the available clinical evidence. We evaluated a treatment reduction approach that reduces the dose and number of antipsychotic medications simultaneously prescribed to patients. METHODS In a randomized open study of the Safe Correction of Antipsychotic Polypharmacy and High-Dose(More)
  • 1